Chinook Therapeutics Inc Cvr (ADRO)
SBC to Revenue
43.09%
Quarterly · Period ending:
ADRO SBC to Revenue
Latest reported43.09%period ending
Latest reported43.09%period ending
ADRO Quarterly SBC/Revenue (436.00% → 43.09%)
Latest values, visible window
High-resolution chart · PNG
ADRO sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 43.0948% | |
| 54.3236% | |
| 14.5878% | |
| 63.9967% | |
| 64.0758% | |
| 68.2488% | |
| 94.0325% | |
| 145.1051% | |
| 137.8061% | |
| 163.9636% | |
| 74.3021% | |
| 116.2407% | |
| 106.0886% | |
| 67.5511% | |
| 105.7264% | |
| 107.1171% | |
| 99.7364% | |
| 8.5302% | |
| 92.8784% | |
| 9.303% | |
| 9.8558% | |
| 27.9773% | |
| 6.0581% | |
| 0% | |
| 6.5969% | |
| 9.6447% | |
| 436% |